News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
THOMAS MCNERNEY & PARTNERS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/25/2022 |
4/A
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Sold 1,663,126 shares
@ $2.53, valued at
$4.2M
Sold 2,061,685 shares
@ $2.53, valued at
$5.2M
Sold 5,722 shares
@ $2.53, valued at
$14.5k
Sold 13,630 shares
@ $2.53, valued at
$34.5k
Sold 1,164 shares
@ $2.53, valued at
$2.9k
Sold 7,585 shares
@ $2.53, valued at
$19.2k
|
|
| 04/21/2022 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on CLARUS THERAPEUTICS INC|
Txns:
| Sold 1,663,126 shares
@ $2.53, valued at
$4.2M
Sold 2,061,685 shares
@ $2.53, valued at
$5.2M
Sold 5,722 shares
@ $2.53, valued at
$14.5k
Sold 13,630 shares
@ $2.53, valued at
$34.5k
Sold 1,164 shares
@ $2.53, valued at
$2.9k
Sold 7,585 shares
@ $2.53, valued at
$19.2k
|
|
| 09/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2017 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc. |
| 02/10/2017 |
SC 13D/A
| THOMAS MCNERNEY & PARTNERS LP reports a 2% stake in Ocera Therapeutics, Inc. |
| 02/02/2017 |
SC 13D/A
| THOMAS MCNERNEY & PARTNERS LP reports a 8% stake in Ocera Therapeutics, Inc. |
| 02/16/2016 |
SC 13D/A
| THOMAS MCNERNEY & PARTNERS LP reports a 12.2% stake in Ocera Therapeutics, Inc. |
| 02/13/2015 |
SC 13D/A
| THOMAS MCNERNEY & PARTNERS LP reports a 12.6% stake in Ocera Therapeutics, Inc. |
| 07/24/2013 |
SC 13D
| THOMAS MCNERNEY & PARTNERS LP reports a 22.2% stake in Ocera Therapeutics, Inc. |
| 07/17/2013 |
4/A
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Acquired 1,675,677 shares
@ $6, valued at
$10.1M
Acquired 762,892 shares
@ $6, valued at
$4.6M
Granted 25,000 options to buy
@ $4, valued at
$100k
Granted 31,835 options to buy
@ $4.24, valued at
$135k
Granted 100,000 options to buy
@ $0.11, valued at
$11k
Granted 25,000 options to buy
@ $0.22, valued at
$5.5k
Granted 25,000 options to buy
@ $0.22, valued at
$5.5k
Granted 161,855 warrants
@ $0.08, valued at
$12.9k
Granted 161,855 warrants
@ $0.08, valued at
$12.9k
|
|
| 02/11/2013 |
SC 13G/A
| THOMAS MCNERNEY & PARTNERS LP reports a 11% stake in Tranzyme, Inc. |
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/06/2011 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on TRANZYME INC|
Txns:
| Converted 2,103,623 shares
@ $0
Converted 78,175 shares
@ $0
Converted 7,988 shares
@ $0
Bought 794,966 shares
@ $4, valued at
$3.2M
Bought 14,568 shares
@ $4, valued at
$58.3k
Bought 2,966 shares
@ $4, valued at
$11.9k
Converted 14,725,374 convertible preferred
@ $0
Converted 547,229 convertible preferred
@ $0
Converted 55,946 convertible preferred
@ $0 |
|
| 11/30/2010 |
4
| THOMAS MCNERNEY & PARTNERS LP (See Footnote (10)) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Converted 490,502 shares
@ $0
Converted 392,585 shares
@ $0
Bought 524,229 shares
@ $4, valued at
$2.1M
Converted 5,123 shares
@ $0
Converted 4,101 shares
@ $0
Bought 5,476 shares
@ $4, valued at
$21.9k
Converted 1,840 shares
@ $0
Converted 1,473 shares
@ $0
Bought 1,967 shares
@ $4, valued at
$7.9k
Converted 4,905,024 convertible preferred
@ $0
Converted 392,585 convertible notes
@ $0 |
|
| 11/29/2010 |
4
| THOMAS MCNERNEY & PARTNERS LP (See Footnote (10)) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Converted 1,152,780 shares
@ $0
Converted 207,159 shares
@ $0
Converted 129,855 shares
@ $0
Bought 173,399 shares
@ $4, valued at
$693.6k
Converted 42,840 shares
@ $0
Converted 7,697 shares
@ $0
Converted 2,379 shares
@ $0
Bought 3,178 shares
@ $4, valued at
$12.7k
Converted 4,380 shares
@ $0
Converted 786 shares
@ $0
Converted 484 shares
@ $0 |
|
| 11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/31/2006 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0
Disposed of 3,680 shares
@ $0 |
|
| 05/31/2006 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/31/2006 |
SC 13G
| THOMAS MCNERNEY & PARTNERS LP reports a 12.9% stake in COLEY PHARMACEUTICAL GROUP, INC. |
| 08/15/2005 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Converted 2,088,616 shares
@ $0
Converted 677,858 shares
@ $0
Converted 7,028 shares
@ $0
Converted 3,316 shares
@ $0
Converted 2,088,616 preferred shares
@ $0
Converted 677,858 preferred shares
@ $0
Converted 7,028 preferred shares
@ $0
Converted 3,316 preferred shares
@ $0 |
|
|
|